 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: BRIUMVI (ublituximab) |
|
***************************************************** |
|
#Post#: 3884-------------------------------------------------- |
|
Briumvi (ublituximab) has FDA approval |
|
By: agate Date: December 29, 2022, 12:09 pm |
|
--------------------------------------------------------- |
|
An announcement from the MS Association of America (MSAA) about |
|
the FDA approval of ublituximab, also known now as Briumvi: |
|
https://bit.ly/3i1pBL4 |
|
#Post#: 3886-------------------------------------------------- |
|
Re: Briumvi (ublituximab) has FDA approval |
|
By: agate Date: December 30, 2022, 1:56 pm |
|
--------------------------------------------------------- |
|
From MedPage Today (December 29, 2022)--"Anti-CD20 Agent Gains |
|
Approval for Multiple Sclerosis": |
|
https://bit.ly/3GtuCW4 |
|
#Post#: 3949-------------------------------------------------- |
|
More on Briumvi (MS Foundation) |
|
By: agate Date: February 28, 2023, 8:31 pm |
|
--------------------------------------------------------- |
|
From the MS Foundation Focus on Research (February 28, 2023; |
|
January 11, 2023)--"FDA Approves New MS Injection Treatment": |
|
https://msfocus.org/About-Us/MSF-News-Articles/2023/2377 |
|
***************************************************** |
